ARCHIVES

Sorafenib Targets AML Driven By Mutant FLT3 Gene

This article is from The Cancer Letter archive.

Vol. 31 No. 2 | February 29, 2008

Download PDF Visit The Full Archive

Related Articles

Clinical Cancer Research Battling Threats, Frei Says

May 15, 1981

In Brief: House Hearing On NCI Budget Is March 16; NIH Reauthorization Sent To Senate Floor

February 14, 1992

Schmidt’s Term On Cancer Panel Expires, No Word On Reappointment

February 28, 1975

Research Funding: Clinton Proposes 2.6% Increase For NIH, Amount Called “Paltry”

February 14, 1997

In Brief: Holleb To Retire In June As ACS Vice President; Consensus Conference On Neurofibromatosis Set

January 23, 1987

Alcohol Consumption Does Not Impact Survival of Breast Cancer

April 26, 2013